92 related articles for article (PubMed ID: 6455900)
1. Assessment of placental function by estimation of testosterone in plasma after an intravenous injection of dehydroepiandrosterone sulphate (DHAS).
Axelsson O; Johansson DB
Acta Obstet Gynecol Scand; 1981; 60(3):301-4. PubMed ID: 6455900
[TBL] [Abstract][Full Text] [Related]
2. Unconjugated oestetrol in plasma in response to an intravenous load of dehydroepiandrosterone sulphate (DHAS) in uncomplicated and complicated human pregnancy.
Axelsson O
Acta Endocrinol (Copenh); 1978 Dec; 89(4):753-62. PubMed ID: 152556
[No Abstract] [Full Text] [Related]
3. A radioimmunoassay for total (unconjugated + conjugated) oestrone in plasma from pregnant women; the response of total oestrone in plasma to an intravenous injection of dehydroepiandrosterone sulphate (DHAS).
Axelsson O; Nilsson BA; Johansson ED
J Steroid Biochem; 1978 Nov; 9(11):1119-23. PubMed ID: 218057
[No Abstract] [Full Text] [Related]
4. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Laskowska M; Laskowska K; Oleszczuk J
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
[TBL] [Abstract][Full Text] [Related]
5. Plasma estrogen response to dehydroepiandrosterone sulphate injection in normal and complicated late pregnancy.
Fraser IS; Leask R; Drife J; Bacon L; Michie E
Obstet Gynecol; 1976 Feb; 47(2):152-8. PubMed ID: 129714
[TBL] [Abstract][Full Text] [Related]
6. Assessment of placental function in normal and pathological pregnancies by estimation of plasma oestradiol levels after injection of dehydroepiandrosterone sulphate.
Korda AR; Challis JJ; Anderson AB; Turnbull AC
Br J Obstet Gynaecol; 1975 Aug; 82(8):656-61. PubMed ID: 126694
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of intrauterine fetal growth retardation by DHAS half-life.
Rabe T; Hösch R; Kiesel L; Runnebaum B; Keller PJ; Kubli F
Eur J Obstet Gynecol Reprod Biol; 1986 Jun; 22(1-2):41-51. PubMed ID: 2941326
[TBL] [Abstract][Full Text] [Related]
8. Assessment of placental function in uncomplicated and complicated late pregnancy by estimation of unconjugated oestrogens in plasma after an intravenous injection of dehydroepiandrosterone sulphate.
Axelsson O; Nilsson BA; Johansson ED
Acta Endocrinol (Copenh); 1978 Oct; 89(2):359-71. PubMed ID: 151472
[No Abstract] [Full Text] [Related]
9. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of intrauterine fetal growth retardation by prolongation of dehydroepiandrosterone sulfate (DHAS) half-life after DHAS loading.
Rabe T; Runnebaum B; Koeppen U; Widmaier G; Kubli F
Eur J Obstet Gynecol Reprod Biol; 1982 May; 13(3):145-58. PubMed ID: 6212274
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test.
Rabe T; Hösch R; Runnebaum B
Biol Res Pregnancy Perinatol; 1983; 4(3):130-6. PubMed ID: 6226324
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function.
Lindoff C; Astedt B
Am J Obstet Gynecol; 1994 Jul; 171(1):60-4. PubMed ID: 8030735
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
14. [Half-life of dehydroepiandrosterone sulfate (DHAS) during pregnancy].
Cohen H; Cohen MM
C R Acad Hebd Seances Acad Sci D; 1976 Jun; 282(22):1875-8. PubMed ID: 133767
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy-specific beta-1-glycoprotein levels in normal and toxemic pregnancy.
Heikinheimo M; Unnérus HA
Obstet Gynecol; 1979 Nov; 54(5):606-10. PubMed ID: 315526
[TBL] [Abstract][Full Text] [Related]
16. Feto-placental steroid metabolism in growth retarded human fetuses.
Reynolds JW; Barnhart BJ; Carlson CV
Pediatr Res; 1986 Feb; 20(2):166-8. PubMed ID: 2935778
[TBL] [Abstract][Full Text] [Related]
17. Association of fetal-derived hypermethylated RASSF1A concentration in placenta-mediated pregnancy complications.
Kim MJ; Kim SY; Park SY; Ahn HK; Chung JH; Ryu HM
Placenta; 2013 Jan; 34(1):57-61. PubMed ID: 23187089
[TBL] [Abstract][Full Text] [Related]
18. Placental metabolism of dehydroepiandrosterone sulphate in normal pregnancy.
Klopper A; Varela-Torres R; Jandial V
Br J Obstet Gynaecol; 1976 Jun; 83(6):478-83. PubMed ID: 132184
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
